Soliton

Allergan Aesthetics, an AbbVie company, completed its acquisition of Soliton, Inc., adding the RESONIC device for cellulite treatment to its body contouring portfolio.

Allergan Aesthetics, an AbbVie company, announced a definitive agreement to acquire Soliton and its RESONIC Rapid Acoustic Pulse device, a non-invasive treatment for cellulite. The acquisition expands Allergan Aesthetics' body contouring portfolio.